Filing Details
- Accession Number:
- 0001127602-16-069111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-05 15:34:57
- Reporting Period:
- 2016-12-02
- Filing Date:
- 2016-12-05
- Accepted Time:
- 2016-12-05 15:34:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1307505 | A Vecheslav Elagin | 3471 River Hills Drive Cincinnati OH 45244 | Evp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-12-02 | 7,883 | $17.30 | 52,926 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 77 | Indirect | Held in Meridian Savings & Investment Plan (401K) |